Skip to main content

Join us Feb. 13 at 11 a.m. ET for “Breaking Barriers with Digital Health Technologies,” unveiling new resources to advance CRS risk prediction and support DHT development. Don’t miss it!

Register here

Join us! On Feb. 25 at 11 a.m. ET DiMe will host a public launch event for The Playbook: Pediatric Digital Medicine. Don't miss the opportunity for a first look and overview of DHT innovation in pediatrics!

Register here

Take the fast track to becoming a V3 and V3+ expert

Learn More

Optimizing treatment of type 2 diabetes using sensor data

Over 38 million Americans live with diabetes, with 90-95% affected by type 2 diabetes (T2D). In addition, T2D often comes with serious comorbidities, including cardiovascular disease, obesity, and kidney complications. 

As treatment options expand and digital health technologies (DHTs) like continuous glucose monitors become essential to care, the opportunity to improve outcomes and tackle these interconnected health challenges has never been greater. However, standing out in a crowded market and demonstrating clinical value to payors, providers, and patients remains challenging.

To address this, DATAcc by DiMe is looking for key leaders—including those in pharmaceutical and medical device manufacturers, digital solution developers, payors, health systems, regulators, and patients—to collaborate and develop holistic, actionable recommendations.

Are you one of those leaders? By joining this project, you will:

  • Lead the development of pathways to position  PGHD from DHTs  as critical evidence that improves T2D treatment and supports decisions
  • Drive the creation of a toolkit integrating PGHD into budget models to enhance market adoption and patient access
  • Influence policy recommendations to advance DHTs and PGHD as essential tools in drug development and patient care
  • Collaborate with stakeholders to improve care for T2D and comorbidities
  • Gain early access to insights and tools that amplify your organization’s impact
  • Position your company as a thought leader in digital health innovation

Name(Required)
This field is for validation purposes and should be left unchanged.

Join us!

Partner with us today to enable the meaningful use of digital health data and insights to support the development of novel treatments, improve patient access, reduce total costs of care, and enhance outcomes for all patients receiving T2D care and related treatments.